Why Life Sciences Translation Requires Scientific Expertise
Life sciences translation occupies a unique position at the intersection of linguistic precision and scientific accuracy. The field encompasses molecular biology, genetics, pharmacology, and clinical research, each with extensive specialised vocabularies and evolving terminology as new discoveries reshape understanding. Translators must not only master these vocabularies but understand the science sufficiently to recognise when something doesn't make sense.
The stakes in life sciences translation are high. Clinical trial protocols must be translated with absolute precision to ensure patient safety and data integrity across international study sites. Regulatory submissions to the FDA, EMA, or MHRA must use exact terminology that regulators expect. Scientific publications must maintain the nuance and precision that peer reviewers demand. Patent applications must use language that protects intellectual property whilst satisfying patent office requirements.
Our life sciences translators hold advanced degrees in relevant fields, PhDs in biochemistry, molecular biology, pharmacology, or related disciplines. Many have research experience in academic or industry settings. They understand experimental methodology, statistical approaches, and the context in which scientific findings are reported. This scientific foundation enables them to translate not just words but meaning.
The UK Life Sciences Translation Landscape
The UK has a thriving life sciences sector, with significant concentrations in the "golden triangle" of London, Oxford, and Cambridge. Biotech companies, pharmaceutical R&D operations, and clinical research organisations all generate substantial translation requirements as they conduct international research and pursue global regulatory approvals.
Key life sciences translation requirements in the UK include:
- Clinical trials, Multi-site international trials require translation of protocols, informed consent forms, patient-reported outcomes, and investigator communications. ICH-GCP compliance demands that patients understand trial materials in their native language
- Regulatory submissions, UK biotech and pharmaceutical companies submit applications to the MHRA for UK approvals, EMA for EU marketing authorisations, FDA for US market access, and other regulators worldwide. Each requires translated documentation meeting specific format and terminology requirements
- Scientific publications, Researchers publish in international journals and present at global conferences. Translation of manuscripts, abstracts, and poster presentations enables broader dissemination of UK research
- Patent applications, Life sciences innovations require patent protection across jurisdictions. PCT applications and national phase filings need translation that protects IP whilst satisfying patent office requirements in each country
Regulatory Submissions and Compliance
Regulatory translation in life sciences requires understanding of both the science and the regulatory frameworks governing drug and device development. Each regulatory authority has specific requirements for translated documentation, and submissions must satisfy these requirements to avoid delays in the approval process.
Our regulatory translation approach includes:
- FDA submissions, IND (Investigational New Drug) applications, NDA (New Drug Application) filings, and BLA (Biologics License Application) submissions have specific requirements. We translate according to FDA guidance documents and established terminology conventions
- EMA submissions, Marketing Authorisation Applications to EMA require documentation in English with specific components potentially requiring translation into other EU languages. We understand the Centralised Procedure, DCP, and MRP requirements
- MHRA submissions, Clinical Trial Authorisations and Marketing Authorisations to MHRA follow UK-specific requirements post-Brexit. We ensure submissions meet current MHRA guidance
- Back-translation and reconciliation, For critical regulatory documents, we provide back-translation from target language to source, followed by reconciliation to verify accuracy. This provides auditable documentation of translation quality
- Audit trail documentation, Regulatory submissions may require translator CVs, signed statements, and quality certifications. We provide complete documentation packages suitable for regulatory inspection
The Lingo Life Sciences Practice: Specialist Services
Life sciences work rarely arrives as a single document. A trial generates consent forms and outcome assessments, an approval generates product information and safety reporting, a device generates instructions and technical files, and an invention generates patents. We run each of these as a dedicated specialist service, all sharing one glossary and one translation memory per client, so terminology stays exact across your whole programme.
- Clinical trial translation: protocols, informed consent, patient materials and linguistic validation of outcome assessments, with the certificates ethics committees expect
- Pharmaceutical translation: SmPCs, PILs and labelling to template discipline, pharmacovigilance on safety-report clocks, GMP and quality documentation
- Medical device translation: IFUs, labelling and device software for MDR, IVDR and UK requirements, delivered as print-ready artwork
- Patent translation: filing-ready specifications and claims for PCT national phase, European validation and litigation
- Healthcare translation: NHS-facing patient communication in community languages
Each service page explains its own scope, process and pricing in depth, and the online quote prices any specific document in minutes.
Linguistic Validation of Outcome Assessments
When a questionnaire measures a study endpoint, translation becomes a measurement problem: the translated instrument must measure the same thing as the original or the data cannot be pooled across countries. Linguistic validation answers that with a defined sequence of dual forward translation, reconciliation, independent back translation, clinician review and cognitive debriefing with target-language respondents, documented in a full audit trail suitable for submission.
We run linguistic validation to recognised good practice as part of our clinical trial translation service, and we scope it honestly: endpoint instruments warrant validation, administrative study documents need excellent standard translation, and we will tell you which of your documents fall on which side of that line before you spend a penny at validation rates.
Pharmacovigilance and Safety Reporting
Safety translation runs on regulatory clocks: expedited case reports are counted in days from first receipt, and a case narrative arriving in Portuguese or Japanese still has to be assessed and reported inside the same window. Our pharmacovigilance work covers individual case narratives, literature surveillance from local journals, periodic safety reports, risk minimisation materials and direct healthcare professional communications produced in parallel across every affected market.
Urgent cases turn around same day through our urgent service, with weekend availability by arrangement for standing pharmacovigilance clients. The full picture, including GMP documentation and product information work, lives on our pharmaceutical translation page.
